ProShares and ProFunds Announce Benchmark Changes for 53 Geared Sector Funds

BETHESDA, Md.--( BUSINESS WIRE )--ProShares and ProFunds, premier providers of leveraged and inverse funds, announced plans to change the underlying indices for a combined 53 sector ETFs and mutual funds to S&P Select Indices.

Business Wire • Jan 5, 2023

5 Best Leveraged/Inverse ETFs of August

Wall Street saw a strong start to August but the rally fizzled in the last couple of weeks, driven by renewed aggressive Fed rate hike speculation.

Zacks Investment Research • Aug 31, 2022

Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)

We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.

Seeking Alpha • Aug 8, 2022

Top Performing Leveraged/Inverse ETFs: 06/05/2022

Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

ETF Trends • Jun 7, 2022

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Seeking Alpha • Apr 16, 2021

Healthcare: A Wide Choice Of Large And Well-Established Companies

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.

Seeking Alpha • Feb 19, 2021

Best Leveraged/Inverse ETFs of June

The month of June started with a bang, extending the two-month bull rally. The optimism over accelerating economic activities as many states reopened, a booming technology sector, an unprecedented stimulus, and hopes of a potential coronavirus vaccine were the biggest catalysts in driving the stocks higher.

Zacks Investment Research • Jun 29, 2020